Neil Paulvin tells me that his midtown office has seen a 50 percent increase in patient inquiries about peptides this year, and William Allen, a marketing manager at the West Villagebased Extension Health, tells me peptide orders to his clinic have essentially doubled compared to what he was seeing in 2025
Now that brand-name versions (like Mounjaro) are widely available, pharmacies can no longer produce their own
Here's how it differs from HA fillers and when it's the better choice
I cant say I used to indulge too much at Dunkin in the past, Im def more a savory gal than a donut gal, but I certainly was more likely to steal a munchkin from the kids in the past
Sweating more
Semaglutide (Ozempic, Wegovy, Rybelsus) Discontinuation : 161% increased risk Nausea : 246% increased risk Vomiting : 325% increased risk Diarrhea : 137% increased risk Tirzepatide (Mounjaro and Zepbound) Discontinuation : 130% increased risk Nausea : 261% increased risk Vomiting : 392% increased risk Diarrhea : 188% increased risk Cagrilintide/semaglutide (CargiSema) Discontinuation: 84% reduced risk Nausea: 721% increased risk Vomiting: 1724% increased risk Diarrhea: 560% increased risk Exenatide (Byetta and Bydureon) Discontinuation: 139% increased risk Nausea: 138% increased risk Vomiting: 182% increased risk Diarrhea: 103% increased risk The study comes just months after the U.S